FENNEC PHARMACEUTICALS INC. (FENC) has 20 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $1.2M. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 15, 2026 | Brughera Marco Maria Director | $127,158 | 46,635 | 0% | Yes | |
|
|
||||||
| Aug. 31, 2026 | Sayad Pierre Sargis Chief Medical Officer | −$144,114 | 12,168 | −55% | No | |
|
|
||||||
| Aug. 31, 2026 | Evans Terry L Chief Commercial Officer | $0 | 168 | +1% | No | |
|
|
||||||
| Aug. 31, 2026 | Cioffi Christiana Marie Chief Strategy Officer | $0 | 156 | +1% | No | |
|
|
||||||
| Aug. 31, 2026 | Hackman Jeffrey S. Chief Executive Officer | $0 | 1,159 | +2% | No | |
|
|
||||||
Showing the 5 most recent of 20 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free